0001665160-25-001394.txt : 20250827 0001665160-25-001394.hdr.sgml : 20250827 20250827145902 ACCESSION NUMBER: 0001665160-25-001394 CONFORMED SUBMISSION TYPE: C/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20250827 DATE AS OF CHANGE: 20250827 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AlphaRose Therapeutics Inc CENTRAL INDEX KEY: 0002051498 ORGANIZATION NAME: EIN: 934193310 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: C/A SEC ACT: 1933 Act SEC FILE NUMBER: 020-35469 FILM NUMBER: 251264278 BUSINESS ADDRESS: STREET 1: 1401 LAVACA STREET, #851 CITY: AUSTIN STATE: TX ZIP: 78701 BUSINESS PHONE: 256-445-8007 MAIL ADDRESS: STREET 1: 1401 LAVACA STREET, #851 CITY: AUSTIN STATE: TX ZIP: 78701 C/A 1 primary_doc.xml C/A 0002051498 XXXXXXXX 020-35469 LIVE false false false true Issuer is updating their offering end date to September 29, 2025. AlphaRose Therapeutics Inc Corporation DE 10-31-2023 1401 LAVACA STREET, #851 AUSTIN TX 78701 https://www.alpharose.com/ N StartEngine Primary, LLC 0001725012 008-70060 7 - 13 percent Three percent (3%) of securities of the total amount of investments raised in the offering, along the same terms as investors. Common Stock 14814 1.35000 N/A 19998.90 Y Other At issuer's discretion, with priority given to StartEngine Owners 4999999.05 09-29-2025 1.00 614498.00 0.00 525845.00 49990.00 0.00 0.00 81098.00 0.00 1151098.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -625253.00 0.00 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY AlphaRose Therapeutics Inc Casey McPherson CEO, Principal Accounting and Financial Officer, and Board Member Casey McPherson CEO, Principal Accounting and Financial Officer, and Board Member 08-27-2025 Alan Edmund Walts Board Member 08-27-2025 Belinda Ann Termeer Board Member 08-27-2025 Lance Hirsch Board Member 08-27-2025